openPR Logo
Press release

Peripheral Arterial Disease Market Research Report by Key Manufacturers Analysis and Forecast 2023

02-28-2017 10:15 PM CET | Health & Medicine

Press release from: Transparency Market Research – Pharmaceutical

Peripheral Arterial Disease Market Research Report by Key

Peripheral arterial disease, also known as peripheral vascular disease is a condition in which the arteries, other than supplying blood to heart and brain narrow down. Peripheral arterial disease mostly affects the legs, though other arteries may also be involved. Peripheral arterial disease is caused by the deposition of fats (plaques) in the artery walls which reduce the blood flow to organs, limbs and head. The population over the age of 50 are at the risk of suffering from peripheral arterial disease. The growing geriatric population, increasing therapies, rising minimally invasive techniques support the growth for peripheral arterial disease market. It has been estimated that globally around 20% of the total population above the age of 60 years are affected by peripheral arterial diseases. High risk factors such as smoking and diabetes contributes towards increase in incidence rate of peripheral arterial diseases which would stimulate the growth of peripheral arterial disease market globally.

The peripheral arterial disease therapeutic market has been segmented into devices, drugs and pipeline. The devices segment is further categorized into devices such as peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA Guidewires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, embolic protection devices and inferior vena cava filters. The peripheral vascular stents accounts for the largest share, followed by peripheral transluminal angioplasty balloon catheters. While emnolic protection devices are the fastest growing segment in the global peripheral arterial disease therapeutic market. The drugs segment can be segmented on the basis of cholesterol-lowering drugs, high blood pressure lowering drug, blood sugar regulating drug, and blood clot preventing drug. The phase III pipeline drugs for peripheral arterial disease include Rivaroxaban (Bayer), DLBS1033 (Dexa Medical Group), clopidogrel (SR25990) (Sonofi), Propionyl-L-Caritine (Sigma-Tau Research, Inc.) and others.

Browse full report on Peripheral Arterial Disease Market -

http://www.transparencymarketresearch.com/peripheral-arterial-disease-market.html

Geographically, peripheral arterial disease therapeutic market has been segmented in North America, Europe, Asia Pacific, Latin America and Rest of the World (RoW). North America, accounted for the largest share in the overall peripheral arterial disease therapeutic market. The dominance is majorly due the high adoption rates of minimally invasive surgeries, higher healthcare expenditure and patient awareness, making North America the leading market for peripheral arterial disease therapeutic market. Europe accounted for the second largest market for peripheral arterial disease therapeutic market. The aging population would boost the demand for peripheral arterial devices in the forecast period. Asia Pacific is anticipated to be the most lucrative market for peripheral arterial disease therapeutic market. The major factors attributing the fastest growth of this region is the presence of large patient pool with unmet medical needs, acting as the opportunity for the players operating in this market. Growing healthcare scenario in the Asian countries coupled with the growing GDP and government initiative would assist the market growth for peripheral arterial disease therapeutics market. South American countries such as Brazil and Mexico are the regions that have significant potential for growth due to developing medical infrastructure, high disposable income and rising prevalence of peripheral arterial disease in the region assisting the market growth. The Rest of the World includes countries such as Russia and countries of Middle East and Africa. The market for peripheral arterial disease therapeutic is subject to grow due to the improving government initiative and rising awareness.

Some of the major players operating in the peripheral arterial disease therapeutics market are Abbott Laboratories, Angioscore, Inc., Edward Lifesciences Corporation, Medtronic Inc., Boston Scientific Corporation, Bayer, Volcano Corporation, Sanofi S.A. and others.

Request for brochure of this report -

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=9506

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peripheral Arterial Disease Market Research Report by Key Manufacturers Analysis and Forecast 2023 here

News-ID: 452677 • Views:

More Releases from Transparency Market Research – Pharmaceutical

Plasma Protease C1-inhibitor Treatment Market Estimated to Flourish by 2025
Plasma Protease C1-inhibitor Treatment Market Estimated to Flourish by 2025
A fresh market intelligence study by Transparency Market Research (TMR) states that the business landscape of the global plasma protease c1-inhibitor treatment market is consolidated with intense competitive rivalry among leading players. TMR detects Shire plc led the global plasma protease C1-inhibitor treatment market in 2016. Key factors that account for its dominance are expanded product portfolio, acquisitions, and widespread market presence. Pharming Group N.V., CSL Limited, and Sanquin are
Narcolepsy Market - Global Industry Trends and Forecast - 2019
Narcolepsy Market - Global Industry Trends and Forecast - 2019
Narcolepsy is a chronic neurological disorder, which is characterized by brain’s inability to control the sleep-wake cycle of an individual. This disorder is not caused due to any mental illness, but is mainly caused due to genetic abnormalities occurring from environmental factors or biologic factors. Narcoleptic individuals exhibita typical characteristic symptom, i.e. excessive daytime sleepiness (EDS), where individuals experience disturbed night sleep and abnormal daytime sleep pattern. Narcolepsy disorder is
Diabetic Macular Edema Market - Key Growth Factors and Forecast 2019
Diabetic Macular Edema Market - Key Growth Factors and Forecast 2019
Macular edema is the condition when the fluid and proteins start collecting on or under the macula of the eye thereby resulting in swelling. Due to such swelling, a person’s central eye vision gets distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME). Obtain Report Details @ http://www.transparencymarketresearch.com/diabetic-macular-edema-market.html Diabetic macular edema is the major reason for loss of vision in patients
Primary Systemic Amyloidosis Market- Get Facts About Business Strategies and Financial Status over Forecast Period 2020.
Primary Systemic Amyloidosis Market- Get Facts About Business Strategies and Fin …
Amyloids are the substance made up of abnormally formed protein in the bone marrow that gets saturated in different tissues or organs of the body. The condition is termed as amyloidosis. There are various types of amyloidosis out of which primary systemic amyloidosis are most common, these are associated with plasma cell dyscrasia and has no historical evidence of disease. Kidney, intestines, liver, heart and nerves are the common organs

All 5 Releases


More Releases for Peripheral

Peripheral Vascular Devices Market - Advancing vascular health: Cutting-edge dev …
Newark, New Castle, USA: The "Peripheral Vascular Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Peripheral Vascular Devices Market: https://www.growthplusreports.com/report/peripheral-vascular-devices-market/7820 This latest report researches the industry structure,
Peripheral Stent Market - Pioneering Solutions for Peripheral Artery Disease: Re …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Peripheral Stent Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Peripheral Stent provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive
Peripheral Vascular Devices Market - Empowering Mobility, Preserving Health: Ele …
Newark, New Castle, USA - new report, titled Peripheral Vascular Devices Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Peripheral Vascular Devices market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Peripheral Vascular Devices market. The report offers an overview of
Peripheral Vascular Devices Market Report 2018: Segmentation by Types (Periphera …
Global Peripheral Vascular Devices market research report provides company profile for Abbott Vascular, Bayer Healthcare, Volcano Corporation, Teleflex Medical and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation
Peripheral Vascular Device Market Size, Peripheral Vascular Device Market Share, …
Global Peripheral Vascular Device Market Size is observed to gain traction owing to the factors such as increasing research and development for developing several new product, and rising funding by the private organizations. Request for Sample of This Research Report @ https://bit.ly/2xjOKpC Top Key Player:- Abbott Laboratories Braun Melsungen AG Boston Scientific Corporation R. Brad, Inc. Cardinal Health, Inc. Medtronic plc. Cook Medical, Inc. Teruma Corporation Jude Medical, Inc. The Spectranetics Corporation Volcano Corporation Peripheral vascular disorder (PVD) is a blood circulation disorder
Peripheral Artery Disease Market By Type (Peripheral Angioplasty Balloons, Perip …
Peripheral artery disease is characterized by plaque built up in the arteries carrying blood from heart to legs, arms, and other limbs. Peripheral artery disease in turn also increases the risk of other cardiovascular disorders such as heart attack, coronary heart disease, stroke, and ischemic attack. Request Sample At: https://www.bigmarketresearch.com/request-sample/1633533 The global peripheral artery disease market generated $3,136 million in 2016, and is projected to reach $4,980 million by 2023, registering a